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ABSTRACT
Transcription on chromatin by RNA polymerase II
(pol II) is repressed as compared with transcription
on histone-free DNA. In this study, we show that
human topoisomerase I (topo I) and yeast topo-
isomerase II (topo II), each of which relax both posi-
tive and negative superhelical tension, reverse the
transcriptional repression by chromatin. In the
presence of bacterial topo I, which can relax only
negative superhelical tension, the transcription is
repressed on chromatin templates. The data
together show that the relaxation of positive super-
helical tension by these enzymes was the key
property required for RNA synthesis from chromatin
templates. In the absence of topoisomerase, tran-
scriptional repression on chromatin depended on
RNA length. The synthesis of transcripts of 100 nt or
shorter was unaffected by chromatin, but repression
was apparent when the RNA transcript was 200 nt or
longer. These ®ndings suggest that transcription on
chromatin templates results in the accumulation of
positive superhelical tension by the elongating poly-
merase, which in turn inhibits further elongation in
the absence of topoisomerase activity.
INTRODUCTION
Transcription of protein-encoding genes involves the recog-
nition of the promoter DNA sequence by general transcription
factors (GTFs), TFIIA, -B, -D, -E, -F and -H, and RNA
polymerase II (pol II) (1). The function of these GTFs on naked
DNA templates in vitro results in a basal level of transcription,
which can be stimulated by sequence-speci®c enhancer
binding proteins plus coactivators. The DNA in the cell is
not naked, but packed into a compact nucleosome-containing
structure known as a chromatin. Nucleosomal DNA poses a
hindrance to the accessibility to the template by different DNA
binding factors and pol II. Thus, the minimal basal set of pol II
transcription factors, which mediate transcription on a naked
template, are not suf®cient for pol II-dependent transcription
on chromatin templates (2±4). One way that cells regulate
accessibility to nucleosomal DNA is through the use of the
complexes that modify chromatin structure.
A separate problem faced by the transcriptional machinery
is the topology of the DNA. Transcription, which involves the
tracking of a bubble of unpaired bases along a double-stranded
DNA helix, transiently introduces superhelical tension in the
DNA. Transcription thus generates a wave of positive
supercoils in the template ahead of the advancing pol II and
negative supercoils in the DNA behind it (5,6). In a living cell,
the supercoiled state of the DNA is modulated by topoisomer-
ases. In yeast, simultaneous inactivation of DNA topoisomer-
ase I (topo I) and topoisomerase II (topo II) reduces rRNA
synthesis, and to a lesser extent mRNA synthesis is reduced
(7±10). This reduction in RNA synthesis in yeast cells can be
attributed to changes in the topology of the DNA template.
Likewise, the transcription of a number of genes by pol II in a
B-lymphocyte tissue culture cell line is sensitive to topo-
isomerase function (11). A direct link between topoisomerase
activity and the transcription process is dif®cult to establish in
these in vivo assays because of the multiple cellular roles of
the topoisomerase and because of the complexity of the
experimental system.
While topoisomerases have been shown to be required for
transcription in cells, these same activities were dispensable
for RNA synthesis in vitro using puri®ed transcription factors
on model templates. We have found, however, that when the
model template is reconstituted in chromatin, then RNA
synthesis is dependent upon the topo IIa activity associated
with the pol II holoenzyme (3). The pol II holoenzyme
function could be replaced using puri®ed core pol II and
puri®ed topo IIa. Speci®c inhibitors of topo II, etoposide and
ICRF-193, which inhibit the relaxation activity of the topo II
via different mechanisms, also inhibit transcription on
chromatin templates. In contrast, these inhibitors have no
effect on transcription from naked DNA templates. These
results suggest that the topo IIa modi®es the DNA in
chromatin in association with other transcription factors (3),
but the mechanism by which the topoisomerase stimulated
transcription on chromatin was unexplained.
The topo IIa was identi®ed in the reaction via its
association with the pol II holoenzyme (3). Since we
hypothesize that the relaxation activity of the topo IIa is the
key for transcription on chromatin templates, we tested in the
current study whether other topoisomerases, besides topo IIa,
will stimulate transcription on chromatin. We found that
topoisomerases that ef®ciently relaxed positive superhelical
tension could stimulate transcription on the chromatin
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template. In addition, we found that the requirement for a
topoisomerase depends on the length of the transcript, and
only the synthesis of longer RNAs, the templates which
accumulate high positive superhelical tension, is sensitive to
the function of a topoisomerase. We further demonstrate that
the requirement for the topoisomerase activity is strictly at the
elongation stage of the transcription reaction. These results
indicate that the accumulation of positive superhelical tension
in front of the elongating pol II is stabilized by nucleosomes,
and this effect is likely to be a critical component of the
transcription process.
MATERIALS AND METHODS
Plasmid templates
G-less cassette construct pG5-E4-array contained the adeno-
viral E4 promoter upstream of a DNA sequence in which there
were no guanines in the coding strand from the transcription
start site to a particular length (25, 50, 100, 200 or 384 bp)
downstream. The total length of all the DNA templates is
~3000 bp. The length of the transcript was determined by the
length of the G-less region and was indicated in each of the
reactions. Upstream of the E4 promoter were ®ve DNA
binding elements that can be bound by the GAL4 fusion
protein. The promoter and G-less transcript sequences are
present in between the ®ve repeats of the 5S rDNA
nucleosome positioning sequences. All transcription reactions
include an internal basal control template, pDML-200 or -390,
consisting of a core adenoviral major late promoter (MLP)
upstream of a 210 or 390 bp G-less cassette. Both the
templates, pG5E4 and pDML, were digested with restriction
endonuclease ClaI or XmnI, respectively, which cleaves
inside the ampicillin resistance gene, and thus these DNAs
have linear topology.
Chromatin assembly
Histones were puri®ed from the chromatin pellet of HeLa
whole cell extracts (12) by solubilizing in the chromatin
medium salt buffer (0.6 M NaCl, 50 mM NaPO4, pH 6.8 and
0.5 mM PMSF), and bound to an hydroxyapatite column.
Puri®ed nucleosomes were eluted by high salt buffer A (2.5 M
NaCl, 50 mM NaPO4, pH 6.8 and 0.5 mM PMSF) (13).
Puri®ed histone octamers and the linear DNA templates, pG5-
E4-array and DML, were mixed in the ratio of 0.8 mg of
histone:1 mg of total DNA. Typically, 8.4 mg of each DNA
template was mixed with 13.5 mg of puri®ed nucleosomes.
Buffer A was added to keep the salt concentration above 1 M
and the total volume was adjusted to 200 ml. The above sample
was then dialyzed against buffer B (1 M NaCl, 50 mM NaPO4,
pH 6.8 and 0.5 mM PMSF) for 20 min. By slowly, over 3 days,
adding buffer C (50 mM NaPO4, pH 6.8, 5% glycerol and
0.5 mM PMSF), the ®nal salt concentration was dialyzed to
100 mM NaCl.
Reconstitution of chromatin using assembly factors was
done essentially the same as in Ito et al. (14). Each assembly
reaction contained 500 ng of each DNA template, 1.4 mg of
HeLa histones, 6 mg of NAP-1, 100 ng of Acf-1 and 120 ng of
ISWI in a 60 ml volume, based upon protocols provided by
J. Kadonaga and C. Wu. Assembly reactions were incubated at
27°C for 5 h and then divided for use in transcription assays.
For these assembly reactions, the templates did not contain the
nucleosome positioning arrays.
Puri®ed DNA topo IIa was obtained from Topogen, Inc.
and topo I was puri®ed from the baculovirus-infected insect
cells (Sf9) (15). The topo I expressing baculovirus was kindly
provided by A. M. Zhelkovsky and C. L. Moore (Tufts
Medical School). The puri®ed bacterial topo I and the yeast
topo II were kindly provided by J. C. Wang (Harvard
University).
Puri®cation of transcription factors
The transcription factors used in this study were puri®ed using
established techniques. Core pol II was puri®ed from calf
thymus using DEAE chromatography and immunoaf®nity
puri®ed with antibody 8WG16. TFIIH was puri®ed from HeLa
whole cell extracts by chromatography using the following
matrices: Biorex70, DEAE Sepharose, bioscale S and bioscale
Q (16). Flag-tagged TFIID was puri®ed from HeLa cells and
recombinant factors were puri®ed from bacteria as described
previously (16,17). The PC4 construct was kindly provided by
M. Meisterernst and puri®ed as described by Kretzschmar
et al. (18).
In vitro transcription assay
Transcription reactions were performed in a 25 ml volume
containing 20 mM HEPES±NaOH, pH 7.9, 20% glycerol,
1 mM EDTA, 6 mM Mg(OAc)2, 90 mM KOAc, 3 mM
dithiotreitol, 4 mM ZnSO4, 0.2 mg/ml BSA, 100 mM each of
ATP and UTP, 2.5 mM CTP, 50 mM 3¢-OMe-GTP and 30 ng of
each template DNA. Proteins included were 100 ng of TFIIA,
60 ng of TFIIB, 4 ng of TFIIE, 100 ng of TFIIF, 40 ng of core
pol II, 0.3 ml of immunoaf®nity-puri®ed TFIID, 0.5 ml of
TFIIH fraction and 100 ng of PC4. Thirty nanograms of
GAL4±VP16 as an activator was included where indicated.
The reactions were incubated at 30°C for 90 min, terminated
and processed using standard procedures (2±4). Dried gels
were exposed to ®lm with an intensifying screen, generally for
16±24 h.
The amount of topoisomerase used per transcription
reaction was normalized according to the relaxation activity
of each enzyme preparation.
Relaxation assay
Relaxation assays with topo I used plasmid DNA (200 ng/
reaction) in a ®nal volume of 30 ml in topo I buffer (10 mM
Tris±Cl, pH 7.9, 1 mM EDTA, 150 mM NaCl, 0.1% BSA,
0.1 mM spermidine, 0.5% glycerol). The activities of the
various topoisomerases were similar when the buffer was the
same as used in transcription reactions (data not shown). The
reactions were incubated at 37°C, terminated by the addition
of 2.5 ml of bromophenol blue and phenol/chloroform
extraction, and then analyzed on 1% native agarose gel.
Gels were stained with ethidium bromide.
RESULTS
Topo I can relieve the repression of transcription due to
nucleosomes
Our earlier data revealed that human topo IIa could reverse
the repression of transcription by nucleosomes (3). It was
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unclear whether this transcription effect was due to a speci®c
function of topo IIa or rather that another topoisomerase could
replace topo IIa. We thus tested whether human topo I could
replace topo IIa function in transcription in chromatin
templates. Transcription reactions contained the basal tran-
scription factors, TFIIA, -B, -D, -F, -E and -H, core pol II and
the PC4 cofactor. Indicated reactions also contained the
GAL4±VP16 activator protein. These puri®ed factor prepar-
ations had no detectable topoisomerase activity (data not
shown). All reactions contained equal concentrations of two
templates. The template encoding a 384 nt G-less RNA was
responsive to GAL4±VP16 since it contained ®ve GAL4
binding sites upstream of the adenovirus E4 core promoter and
a G-less cassette. The 150 bp promoter and G-less transcript
sequences are bracketed on each side by ®ve repeats of the 5S
rDNA nucleosome positioning sequence. The total size of the
template DNA containing the G-less cassette was ~3000 bp.
The second template contains the adenovirus MLP upstream
of a 210 bp G-less cassette. This template lacks GAL4 binding
sites, and is thus a basal transcription control. Both templates
were reconstituted in chromatin using puri®ed histone
octamers by an established procedure.
As observed in earlier studies, transcription by core pol II is
repressed on chromatin templates (Fig. 1A, lanes 1 and 2).
Consistent with our previous results (3), in the presence of
0.3 U topo IIa, the transcriptional repression by chromatin
was reversed (Fig. 1A, lanes 3 and 4). Topo I and topo IIa,
though structurally very different, share a common activity,
i.e. both can relax negative and positive superhelical DNA
torsion. Indeed, when 5 ng of topo I was included in
transcription reactions with chromatin templates, a high
level of product RNA was observed for the GAL4±VP16-
stimulated transcript (Fig. 1A, lanes 5 and 6). This result
indicated that under these conditions, either topoisomerase
activity was suf®cient for RNA synthesis on chromatin
templates.
Chromatin templates were prepared by a standard dialysis
technique (13), using puri®ed histone octamers (Supple-
mentary Material Fig. S1A), linearized DNAs, with or without
puri®ed topo I (Supplementary Material Fig. S1B). Digestion
of chromatin templates with micrococcal nuclease revealed
mononucleosomes and polynucleosomes, with a spacing of
~160 bp, consistent with multiple nucleosomes per DNA
plasmid template, and the presence of topo I had no effect on
the chromatin assembly (Fig. 1B). When using the highly
puri®ed transcription factors, the topo I was most effective in
stimulating transcription when it was included in the
chromatin assembly reaction (data not shown). When using
less pure protein preparations, a second activity can load the
topoisomerase on to the template after chromatin assembly
(3). These ®ndings suggest that the topoisomerase must be
embedded in the chromatin in order to stimulate transcription
on chromatin.
Since several of the transcription factors were prepared
from eukaryotic cells, it was possible that remodeling
activities, or other chromatin-regulating activities, might
contaminate the preparations. Transcription factors puri®ed
from cells, TFIID, TFIIH and pol II, were tested for the
presence of the chromatin-speci®c elongation factor, FACT
(2) by immunoblotting for the FACT subunit SSRP1. Using
this analysis, these protein preparations had no detectable
FACT (data not shown). We tested whether there is a
chromatin remodeling activity (19) present in the core pol
II, TFIID, TFIIH, topo IIa and topo I preparations that is
contributing to the transcriptional activation which is being
observed on chromatin templates. For testing the protein
preparations, we used 4-fold more protein than is used in a
typical transcription reaction in order to reveal low level
contaminating remodeling activities. As shown in Supple-
mentary Material Figure S2, the pol II, TFIID, TFIIH, topo I
and topo IIa preparations each had no detectable remodeling
activity.
We next tested whether the effect of chromatin on
transcription was dependent upon the method for preparing
chromatin. We have been applying puri®ed histone octamers
directly onto the DNA templates by the salt dialysis technique.
Figure 1. Either topo IIa or topo I reversed the repression of transcription
on chromatin. (A) Transcription reactions were tested on chromatin tem-
plates which were reconstituted either in the absence of topoisomerase
(lanes 1 and 2) or in the presence of topo IIa (topo II, lanes 3 and 4) or
topo I (topo I, lanes 5 and 6). Reactions contain pol II, TFIIA, -B, -D, -E,
-F, -H and coactivator PC4. GAL4±VP16 was included in indicated lanes.
Reactions contained two templates in equal concentration, encoding a 384 nt
GAL4-responsive transcript (Stim.) and 210 nt basal control transcript
(Basal). (B) Micrococcal nuclease digestion of chromatin templates.
Chromatin templates were reconstituted either in the absence (lane 1) or in
the presence of topo I (lane 2) with the puri®ed histone octamers and ana-
lyzed by micrococcal nuclease digestion. The agarose gel was stained with
ethidium bromide and the negative of the image is shown. (C) Transcription
reactions were performed on either naked DNA templates (lanes 1 and 2) or
on chromatin templates reconstituted using the Drosophila assembly factor
Acf-1/ISWI and the chaperone NAP-1 (lanes 3±4). Human topo I and
GAL4±VP16 were included in the indicated lanes. (D) Chromatin templates
were reconstituted in the presence of Drosophila assembly factors either in
the absence (lane 2) or the presence (lane 3) of topo I and analyzed by
micrococcal nuclease assay. 100 bp markers are shown in lane 1. The image
is a negative of an ethidium bromide stained gel.
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We tested whether the use of chromatin assembly factors
affected the transcription results. The templates used in
Figure 1C were prepared in a comparatively rapid reaction in
the presence of Drosophila assembly factors (Acf-1, ISWI and
NAP-1), and human topo I was included in reactions as
indicated. The presence of topo I did not affect the chromatin
assembly, as determined by micrococcal nuclease digestion
analysis of the samples (Fig. 1D). In the absence of topo I,
transcription on chromatin templates was repressed (Fig. 1C,
lane 3). Interestingly, inclusion of the chromatin assembly
factors in the transcription reactions resulted in transcription
that was still active in the absence of a topoisomerase, albeit at
low levels. The inclusion of the topoisomerase in the reaction
stimulated the level of RNA synthesis above the repressed
level (Fig. 1C, lane 4). These data clearly show that the
stimulation of transcription on chromatin by topoisomerase is
not wholly dependent upon a technical method.
We tested whether topo I and topo IIa, which are required
for transcription on chromatin templates, can function as
coactivators on naked DNA templates (20,21). Data shown in
Supplementary Material Figure S3 reveal that both topo I and
topo IIa can function as transcriptional coactivators, but only
at a higher concentration than stimulates transcription on
chromatin. Published experiments of topo I as a coactivator on
naked DNA templates required topo I concentrations 40-fold
higher per reaction (21) than stimulated transcription on
chromatin in this study. This result suggests that the activity of
topoisomerases as stimulators of transcription on chromatin
templates is fundamentally different to the coactivator func-
tion of these proteins.
Topoisomerase activity inhibitors repress transcription
on chromatin
Next we used topoisomerase activity inhibitors to test whether
it is the relaxation activity of the topoisomerase or protein±
protein interactions that are required for the core pol II to
overcome the repression by nucleosomes. Camptothecin
speci®cally inhibits the relaxation activity of topo I, and
etoposide speci®cally inhibits the relaxation activity of topo II.
In Figure 2, chromatin templates were reconstituted either in
the presence of puri®ed topo I or topo IIa. Different amounts
of camptothecin or etoposide were included in GAL4±VP16-
stimulated transcription reactions and the effect of topo-
isomerase inhibitor on RNA synthesis was assessed. In
Figure 2A, in the presence of topo I, RNA synthesis was
decreased in the presence of 40 mM camptothecin and it was
further inhibited at 80±160 mM camptothecin (lanes 4±6).
Etoposide, which inhibits topo II relaxation activity, had no
effect on these reactions (lane 8). In contrast, when transcrip-
tion reactions contained topo IIa, 80 mM etoposide inhibited
the GAL4±VP16-stimulated transcription, whereas campto-
thecin had no effect on RNA synthesis (Fig. 2B). These results
strongly demonstrate the speci®city of the topoisomerase
function in transcription on chromatin templates and also
that the speci®c topoisomerase poison only inhibited tran-
scription when the reaction was dependent upon the relevant
topoisomerase.
The topo I-dependent transcription reaction was inhibited
by 40±160 mM camptothecin as shown in Figure 2A. This
concentration is quite high as compared with the concentration
required to inhibit the topo I relaxation activity in vitro (15). It
Figure 2. Speci®city of inhibition of transcription by topoisomerase poisons. (A) Chromatin templates were reconstituted in the presence of topo I.
Transcription reactions were performed on these reconstituted chromatin templates either in the absence (lanes 1, 2 and 7) or the presence of the indicated
concentrations of camptothecin (lanes 3±6) and etoposide (lane 8). GAL4±VP16 was included in lanes 2±8. (B) Chromatin templates were assembled in the
presence of topo IIa and analyzed for GAL4±VP16-stimulated transcription. The indicated concentrations of etoposide (lane 3) and camptothecin (lanes 5 and
6) were included in the reactions. GAL4±VP16 was included in lanes 2±8. (C) The inhibitory concentration of camptothecin for topo I-dependent relaxation
of supercoiled plasmid DNAs was analyzed in 15 min reactions. The ®gure shows an inverted image of an ethidium bromide stained agarose gel. Relaxation
activity is present if the rapidly migrating supercoiled plasmid (Sc.) is converted to the relaxed form (Rel.). The inhibitory effect is ascertained by the
retention of supercoiled plasmid. (D) Relaxation assays were repeated as in (C) with the exception that the time of incubation was 90 min.
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was possible that the long incubation time required for
transcription assays affected the inhibition activity of the
camptothecin. We tested the dependence of time of incubation
on effective concentrations of camptothecin in the relaxation
assay. We incubated the supercoiled DNA with topo I, either
in the absence of camptothecin or in the presence of different
amounts of camptothecin for 15 or 90 min (Fig. 2C and D). We
observed that when the incubation time was 15 min, 5 mM
camptothecin signi®cantly reduced the relaxation activity and
10 mM camptothecin nearly eliminated the relaxation activity
of topo I (Fig. 2C, lanes 2±4). In reactions in which the
incubation time was 90 min, similar to the incubation time for
in vitro transcription reactions, higher concentrations of
camptothecin were required to inhibit the relaxation activity
(Fig. 2D). In these longer assays a reduction in the relaxation
activity was observed only in reactions containing campto-
thecin at concentrations higher than 40 mM. These results
suggest, that given long incubation times, the residual topo I
activity in the presence of 5±20 mM camptothecin is suf®cient
to relax superhelical tension in DNA. Since 90 min reactions
require higher concentrations of camptothecin for inhibition of
relaxation, the results in the relaxation assay in Figure 2D are
consistent with the effect of 40±160 mM camptothecin on
transcription in Figure 2A.
Non-human topoisomerases: yeast topo II, but not
bacterial topo I, stimulates transcription on chromatin
templates
The above data show that relaxation activity of human
topoisomerase enzymes (topo IIa and topo I) rescued the
transcription on chromatin templates. Next we tested the effect
of non-human topoisomerase enzymes, yeast topo II and
bacterial topo I, in transcription on chromatin templates. (Both
enzymes were the gift of J. C. Wang, Harvard University.)
Yeast topo II relaxes both positive and negative superhelical
tension whereas bacterial topo I relaxes negative supercoils
only.
Chromatin templates were reconstituted either in the
absence or in the presence of yeast topo II and activated
transcription reactions were tested on these templates.
Concentrations of the various topoisomerases used for tran-
scription on chromatin templates were all normalized accord-
ing to the relaxation activities (data not shown). In the
presence of yeast topo II, GAL4±VP16-stimulated transcrip-
tion was observed (Fig. 3A, lane 2). Thus, yeast topo II
rescued transcription on chromatin templates. Next the effect
of bacterial topo I on transcription from chromatin templates
was evaluated. In the presence of bacterial topo I, synthesis of
the GAL4±VP16-stimulated RNA remained repressed
(Fig. 3B, lane 4). The amount of bacterial topo I included in
reactions had been normalized with the other topoisomerase
preparations according to the relaxation activity on negatively
supercoiled plasmid DNA. We tested higher and lower
concentrations of bacterial topo I in transcription on
chromatin, and in no case was that topoisomerase as effective
as human topo I in stimulating transcription (Fig. 3B). Thus,
while human topo I, human topo IIa and yeast topo II could
each reverse the repression of transcription by chromatin in
this experimental setting, bacterial topo I could not. These
results suggest that the transcriptional repression by chromatin
is reversed only by those topoisomerase enzymes which
ef®ciently relax positive superhelical tension.
The requirement for topo I in transcription is dependent
on the length of the transcript
We predict that the topoisomerase activity in transcription on
chromatin DNA is required to relax superhelical tension that
accumulates during elongation. According to this model,
synthesis of short transcripts would not be affected by
chromatin. As the GAL4±VP16-responsive template encoded
a 384 nt transcript, we generated templates that would yield
shorter transcripts for this analysis. Different lengths of G-less
cassettes were fused downstream of promoters containing ®ve
repeated GAL4 binding sites, keeping the total length of the
DNA to ~3000 bp. Transcript lengths were 25, 50, 100, 200
and 384 nt. If the initiation step is limiting and responsible for
the repression, then the repression by chromatin would be
independent of the length of the RNA transcript. In contrast, if
polymerase elongation is repressed by the nucleosome-bound
template, then the length of the transcript would be a critical
parameter, and with the increase in length the amount of
repression should increase.
Activated transcription was tested on these naked templates
(Fig. 4A). In alternate lanes GAL4±VP16 was included and
Figure 3. Yeast topo II, but not bacterial topo I, stimulates transcription on chromatin templates. (A) Chromatin templates were reconstituted either in the
presence of yeast topo II (Y topo II) (lanes 1 and 2) or in the absence of topoisomerase (lanes 3 and 4) and were tested in transcription assays. GAL4±VP16
was included in alternate lanes. (B) Transcription on naked DNA templates (lanes 9 and 10) was compared with transcription on chromatin templates
reconstituted with human topo I (lanes 7 and 8) or with an equivalent amount of bacterial topo I (B Topo I), as determined by relaxation activity (lanes 3
and 4). In the indicated lanes, 3-fold lower bacterial topo I or 3-fold higher amounts of bacterial topo I were included. GAL4±VP16 was included in even
number lanes.
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accumulation of the GAL4-responsive transcript was assayed
(lanes 2, 4, 6, 8 and 10). In all the reactions, except in lanes 7
and 8, we included the basal template that encoded a 210 nt
transcript. In lanes 7 and 8, since the activator-responsive
template generated a transcript of 200 nt, we used a basal
template that encoded a 390 nt transcript. When using naked
templates, encoding RNAs ranging from 25 to 384 nt, the level
of activated transcription was unaffected. This result indicated
that on naked DNA templates, transcriptional activation by
GAL4±VP16 stimulated the initiation process or early
elongation events such as promoter clearance, consistent
with prior observations (22,23). Next we tested the same
templates, reconstituted in chromatin in the absence of a
topoisomerase activity. GAL4±VP16-stimulated transcription
was observed in reactions encoding 25, 50, 100 or 200 nt
RNAs (Fig. 4B, lanes 2, 4, 6 and 8). In contrast, transcription
of the 384 nt RNA was repressed even when the activator was
added (Fig. 4B, lane 10). From this result we conclude that the
repression of GAL4±VP16-stimulated transcription by chro-
matin is primarily due to inhibition of elongation. These
results from Figure 4 indicate that RNA synthesis occurs on
short templates, but whether there was partial repression of
transcription, relative to RNA synthesis from naked templates,
could not be determined.
In order to test for partial repression, we directly compared
each length of transcript for activated transcription on the
different templates. Figure 5A shows activated transcription
on a DNA template containing GAL4-response elements
which yields a transcript of 384 nt. As was observed in
previous experiments (Fig. 1), when reconstituted in chroma-
tin, in the absence of topo I, repression of transcription was
observed (Fig. 5A, lanes 3 and 4) whereas in the presence of
topo I, the polymerase was almost as active as when
transcribing the naked DNA template (lanes 1±2 and 5±6).
When the GAL4-responsive template encoded a 200 nt RNA,
the level of activated transcription on the chromatin template
in the absence of topo I was decreased as compared with the
chromatin template in the presence of topo I or the naked DNA
(Fig. 5B). While transcription of the 384 nt RNA was nearly
completely repressed, transcription of the 200 nt RNA on
chromatin in the absence of topoisomerase was decreased by
approximately half. No difference in the level of transcription
was observed when similar reactions were performed on
different forms of the DNA template that encoded 100, 50 or
25 nt transcripts (Fig. 5). From these shorter transcripts, the
transcription level remained the same even when we used
chromatin templates which were reconstituted in the absence
of topo I. These results indicate that when using GAL4±VP16
and puri®ed transcription factors, the repression by chromatin
is dependent upon the length of the nascent RNA.
Transcription on chromatin was not repressed at the initiation
stage of the reaction since all three template conditions were
equally well transcribed when using 25, 50 or 100 nt
templates. Signi®cant repression by chromatin was detected
only when the nascent RNA was 200 nt or longer. This
repression of the synthesis of longer transcripts was reversed
by topo I.
The above results show that the repression by nucleosome-
bound DNA in the absence of a topoisomerase is at the
elongation stage. When using the 384 nt template, shorter
transcripts were not apparent (e.g. Fig. 1A). Since such
abortive transcripts would not be focused in a single band, we
hypothesized that if the elongation block were removed, then
the 384 nt transcript would be apparent. To check this,
chromatin templates were assayed for transcription in the
absence of topo I. After the typical 90 min reaction, the
reaction was treated with either low salt (0.045 M KOAc,
Fig. 6, lane 1) or with 2.5 M NaCl (lane 2). At high salt
concentration, the nucleosomes will dissociate and thus the
superhelical torsion will diffuse off the end of the DNA, as in
naked DNA templates. After treating with high salt, the
samples were passed through a Sephadex G-50 column, which
had been equilibrated at 90 mM KOAc. This maneuver
dissociated the histone octamers from the template, and the
rapid change to 90 mM KOAc would prevent reformation of
chromatin. In addition, passage through a Sephadex column
removed unincorporated radionucleotide triphosphates. After
addition of Mg(OAc)2 and cold ATP, UTP and CTP,
transcription elongation was allowed to continue for another
30 min. Newly initiated transcripts would not be labeled, thus
Figure 4. Repression of transcription on chromatin templates was dependent upon the length of the transcript. (A) Naked DNA templates containing different
lengths of G-less cassette were assayed by GAL4±VP16-stimulated transcription. All of the reactions contain two templates in equal concentrations, encoding
GAL4-responsive transcripts of varying lengths (Stim.) and a basal control transcript (Basal). Reactions containing the 25 nt transcript were analyzed on a dif-
ferent gel from the other samples. When analyzing the 200 nt GAL4-responsive transcript, the basal control was 390 nt (lanes 7 and 8). In all other reactions,
the basal control was a 210 nt RNA. (B) In vitro transcription reactions as in (A), except that the templates were reconstituted in nucleosomes.
GAL4±VP16-stimulated RNAs are indicated by arrowheads.
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this assay detected only those transcripts that paused in the
presence of nucleosomes. The appearance of product RNA
was dependent upon disruption of the nucleosomes using high
salt (Fig. 6, lane 2). This result is consistent with the model
that nucleosomes stabilize the accumulation of positive
superhelical tension that arises as a byproduct of the
transcription process. Removal of the nucleosomes from
templates containing stalled pol II allowed the diffusion of the
inhibitory superhelical tension and transcription elongation
could recommence.
DISCUSSION
Transcription is repressed on chromatin templates. While
DNA accessibility in chromatin has been a focus for much of
the research in this ®eld, in this study we establish that DNA
superhelical tension in chromatin is an important parameter
which affects the ef®ciency of RNA pol II elongation. Our
prior results had revealed that topo IIa is required for
transcription on chromatin, but the mechanism underlying the
requirement was not demonstrated (3). In this study we
demonstrate that the topoisomerase is important during the
elongation step of RNA synthesis. During transcription,
positive supercoils are generated in front of the elongating
RNA pol II and negative supercoils behind it (5,24). From our
data, we conclude that nucleosomes block superhelical tension
from diffusing. The introduction of superhelical tension
during transcription thus results in hyperwinding of the
downstream template and inhibition of transcription
elongation.
On the basis of our results, we propose a model (Fig. 7)
which shows that in the presence of a topoisomerase enzyme
active on positively oriented superhelical turns, the repression
of transcription on chromatin templates is reversed. For the
purposes of the diagram, the DNA template is shown as a long
linker bracketed by nucleosomes. Based upon micrococcal
nuclease digestion patterns, the separation between nucle-
osomes in our templates is signi®cantly shorter, no more than
20 bp. We believe that the interaction between pol II and
Figure 6. Transcription on chromatin templates is blocked at elongation.
Chromatin templates were reconstituted in the absence of topoisomerase
enzyme and assayed for activated transcription as usual (90 min). The
samples were then either treated with 2.5 M NaCl (lane 2) or with low salt
(lane 1) for 5 min and then subjected to gel ®ltration on a Sephadex G-50
column, chased with cold ATP/UTP/CTP for 30 min. The reactions were
terminated and then analyzed. The 384 nt GAL4-responsive transcript
(Stim.) and the 210 nt basal control transcript (Basal) are indicated.
Figure 5. Topo I stimulated transcription of RNAs 200 nt or longer from chromatin templates. (A) GAL4±VP16-stimulated transcription of the 384 nt RNA
was analyzed using chromatin templates containing topo I (lanes 1 and 2), chromatin without topo I (lanes 3 and 4) or naked DNA (lanes 5 and 6). Each reac-
tion contained 30 ng of the GAL4-responsive template DNA and 30 ng of the basal template DNA. GAL4±VP16 was included in even lanes. (B) GAL4±
VP16-stimulated transcriptions were analyzed as in (A) except that the GAL4-responsive template encoded a 200 nt RNA, and the basal control template
encoded a 390 nt RNA, by changing the length of the G-less cassette and keeping the rest of the DNA template the same. (C) As in (A), except that the
GAL4-responsive template encoded a 100 nt RNA. (D) As in (A), except that the GAL4-responsive template encoded a 50 nt RNA. (E) As in (A), except
that the GAL4-responsive template encoded a 25 nt RNA.
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nucleosome-bound template is more complex, but this would
be dif®cult to diagram. According to this model, as elongation
proceeds, positive superhelical torsion accumulates (dia-
gramed as DNA with extra turns). A corollary of this model
is that, since the process of elongation results in the
accumulation of superhelical tension, only long transcriptional
units (G-less cassettes) will accumulate suf®cient superhelical
tension to block further elongation. This corollary is consistent
with the transcript length dependence revealed in this study.
Transcripts of 200 nt and above were signi®cantly repressed.
Clearly, most pol II transcripts are signi®cantly longer than
this, and it is readily extrapolated that this property will be
important in transcription in general. Indeed, transcription in
cells has been shown to be affected by topoisomerase function.
Topo I has been detected at loci of Drosophila polytene
chromosomes that are transcriptionally active (25). The rates
of pol I and pol II transcription were inhibited when anti-topo I
antibody was microinjected into the nuclei of Chironomus
tentans salivary gland cells (26), and the topo I inhibitor
camptothecin repressed rRNA synthesis (27). Double tem-
perature sensitive mutants of topo I and topo II in yeast grown
at the restrictive temperature resulted in the reduction of
rRNA, and to a lesser extent mRNA, synthesis (7,10). Treating
cells with inhibitors of topo I or topo II results in the rapid
decrease in the pol II-dependent transcription activity of
certain genes (11). These results all suggest that within the
complex milieu of the nucleus of the cell, topoisomerase
function can be linked with transcription function. Our results
demonstrate the topoisomerase function in transcription in a
de®ned biochemical system, and also suggest a model for the
requirement.
Our results indicate that pol II elongation is a critical
limiting step for transcription on chromatin templates. In
contrast to our results, initiation of transcription by pol II has
been found in other studies to be repressed by nucleosomes
(28). It is unclear why there is no block to initiation in our
assay system while there is in other systems. Perhaps the
sources of transcription factors contribute to the different
results. Similar to our current results, other studies have also
indicated that elongation is the critically regulated step in the
transcription by pol II on chromatin templates (29), although a
role for topoisomerases in elongation was not identi®ed.
It is possible that there are alternate pathways, which
modify the chromatin structure to bypass the topoisomerase
requirement. These pathways would involve chromatin
remodeling complexes, such as SWI/SNF, which have been
found to increase negative superhelical tension on the DNA
(30) and would thus neutralize the effect of positive super-
helical tension. Alternatively, histone acetyl transferases, or
other complexes that covalently modify the nucleosome, could
potentially regulate the superhelical tension on chromatin.
One possibility is that acetylation of histones alters the
property of nucleosomes in functioning as a barrier to the
diffusion of superhelical tension. If true, then acetylation of
histones would not only mark sites for chromatin binding
proteins, but also make the chromatin permissive to ef®cient
elongation.
Topoisomerase inhibitors are used as drugs for the
treatment of malignancies. In human cells, death associated
with the topoisomerase inhibitors occurs in both the S and G1
phases of the cell cycle. As an example of this principle, the G1
effects of the topo II poison etoposide (31±33) are most easily
consistent with a transcription function for topo II. Perhaps the
cytotoxic effect of these topo I and topo II targeting drugs
occurs via the transcription function.
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